Poe-Jou Chen
Vorstandsvorsitzender bei Cali Biosciences Co. Ltd.
Profil
Poe-Jou Chen is currently the Chief Executive Officer & Executive Director at Cali Biosciences Co. Ltd.
and also holds the position of Chief Executive Officer & Director at Cali Shenzhen Biosciences Co. Ltd.
In the past, he worked as an Executive Director-Clinical Management at PPD Pharmaceuticals Research & Development Beijing Co. Ltd., Executive Director-Project Management at Wuxi Cds Clinical Research Shanghai Co. Ltd., Senior Vice President-Clinical Development at Aprinoia Therapeutics, Inc., and General Manager at Ubp Greater China Shanghai Co. Ltd.
Dr. Chen holds a graduate degree from Massachusetts Institute of Technology, a graduate degree from National Central University, and an undergraduate degree from National Tsing-Hua University.
Aktive Positionen von Poe-Jou Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Vorstandsvorsitzender | 17.03.2021 |
| Cali Shenzhen Biosciences Co. Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Poe-Jou Chen
| Unternehmen | Position | Ende |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 |
| Ubp Greater China Shanghai Co. Ltd. | Corporate Officer/Principal | 01.11.2018 |
| PPD Pharmaceuticals Research & Development Beijing Co. Ltd. | Corporate Officer/Principal | 01.11.2016 |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | Corporate Officer/Principal | 01.06.2014 |
Ausbildung von Poe-Jou Chen
| National Central University | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| National Tsing-Hua University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Shenzhen Biosciences Co. Ltd. | |
| Ubp Greater China Shanghai Co. Ltd. | |
| PPD Pharmaceuticals Research & Development Beijing Co. Ltd. | |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. |
